Join to access to all OVN content. Join for Free
Managed Care MSLs-Past, Present and Future
Managed Care MSL Health Plans Medical Science Liaison MSL Skills Integrated Delivery Networks

Managed Care MSLs-Past, Present and Future


Share This Article


Summary

In this episode, Todd Wandstrat delves into the intricate world of managed care and its intersection with the Medical Science Liaison (MSL) role. He offers a comprehensive overview of managed care's history, including health plans, PBMs, and integrated delivery networks. Todd shares insights into the evolving role of MSLs in this sector, highlighting the unique customer base and value proposition they bring. He discusses the necessary skills and career pathways for aspiring managed care MSLs, emphasizing the importance of presentation skills and resume building. The conversation also touches on navigating the MSL role during COVID, fostering KOL relationships, and the significance of internal collaboration and innovative thinking.

Check out my latest podcast with Todd Wandstrat, Sr Director of Field Based Medicine who discusses Managed Care MSLs… Past, Present and Future

Todd shares…

 The historical perspective of the Managed Care Market and the MSL
 What is a Managed Care MSL
 What skills are mandatory and how can an MSL transition
 What does the future look like for MSLs

Click for Source
Managed Care MSL, Health Plans, Medical Science Liaison, MSL Skills, Integrated Delivery Networks

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN